Skip to main content

Table 1 Patient demographics - ITT set

From: A multicentre, randomised, double-blind, single-dose study assessing the efficacy of AMC/DCBA Warm lozenge or AMC/DCBA Cool lozenge in the relief of acute sore throat

Variable

AMC/DCBA

Warm lozenge

AMC/DCBA

Cool lozenge

Unflavoured,

non-medicated

lozenge

Overall

Number of patients (n)

77

74

74

225

Age (year) (Mean ± SD)

30.3 ± 12.2

32.4 ± 14.7

32.6 ± 13.2

31.7 ± 13.3

Gender (% male)

41.6

39.2

41.9

40.9

Race (% Caucasian)

97.4

97.3

95.9

96.9

Alcohol drinker (%)

83.1

86.5

75.7

81.8

Current smoker (%)

36.4

37.8

35.1

36.4

Former smoker (%)

26.0

17.6

14.9

19.6

Duration of sore throat (days) (Mean ± SD)

2.3 ± 0.8

2.2 ± 0.7

2.0 ± 0.9

2.2 ± 0.8

Duration of URTI (days) (Mean ± SD)

3.0 ± 2.7

2.4 ± 1.0

3.6 ± 7.1

3.0 ± 4.4

  1. SD, standard deviation; URTI, upper respiratory tract infection.